Peter Kolchinsky latest buys and sells

17 complete sales in Peter Kolchinsky's latest 13F filing, largest first. The largest is the sale of the whole position in DNTH, $219.2M or 1.9% of the reported portfolio.

Complete sales
17
Combined size
$783.7M

Key facts

Complete sales
17
Largest move
DNTH, $219.2M
Latest filing
Aug 14, 2026
Peter Kolchinsky ✕

From RA Capital Management's filing for (Q2 2026), filed , against the filing for Mar 31, 2026.

Peter Kolchinsky: buys and sells, latest filings
#StockMoveSharesSizeOf portfolio
1Dianthus Therapeutics IncDNTH▼ Sold out—$219.2M1.90%
2Praxis Precision MedicinesPRAX▼ Sold out—$120.4M1.05%
3Sarepta Therapeutics IncSRPT▼ Sold out—$84.9M0.74%
4Spyre Therapeutics IncSYRE▼ Sold out—$81.8M0.71%
5Fulcrum Therapeutics IncFULC▼ Sold out—$46.4M0.40%
6Olema Pharmaceuticals IncOLMA▼ Sold out—$38.8M0.34%
7Design Therapeutics IncDSGN▼ Sold out—$31.6M0.27%
8Travere Therapeutics IncTVTX▼ Sold out—$22.2M0.19%
9Grail IncGRAL▼ Sold out—$22.1M0.19%
10Relmada Therapeutics IncRLMD▼ Sold out—$20.5M0.18%
11Sutro Biopharma IncSTRO▼ Sold out—$17.8M0.15%
12Contineum Therapeutics IncCTNM▼ Sold out—$16.9M0.15%
13Inspire Med Systems IncINSP▼ Sold out—$16.8M0.15%
14Hinge Health IncHNGE▼ Sold out—$14.1M0.12%
15GeneDx Holdings CorpWGS▼ Sold out—$13.5M0.12%
16Atrium Therapeutics IncRNA▼ Sold out—$11.6M0.10%
17Maplight Therapeutics IncMPLT▼ Sold out—$5M0.04%

Questions and answers

What did Peter Kolchinsky sell last quarter?

The largest sales in the latest 13F filing: DNTH, $219.2M; PRAX, $120.4M; SRPT, $84.9M; SYRE, $81.8M; FULC, $46.4M; OLMA, $38.8M.

How is the size of a buy or sell worked out?

As the change in shares at the price the filing implies for the quarter's end (reported value divided by shares) — an estimate of the trade, not what was paid. A position sold out is sized at its value in the previous filing.

Learn

Cite this page

Funkfolio, “Peter Kolchinsky: buys and sells, Q2 2026 13F”, data as of 14 August 2026. https://funkfolio.com/gurus/activity?type=sold&investor=peter-kolchinsky

Underlying data: SEC EDGAR, Form 13F-HR.

Source: SEC EDGAR, Form 13F-HR. A move is a change in share count between an investor's latest filing and the one before; a share split in between is allowed for where one is on record. Size is the shares bought or sold at the price the filing implies for the period end (reported value ÷ shares) — an estimate of the trade, not what was paid — and a position sold out is sized at its value in the previous filing. “Of portfolio” sets that size against the portfolio reported for the period. Only each investor's 150 largest positions and 50 largest exits are read. Filings appear up to 45 days after the quarter ends; none of this is advice.